Lehmann William Jr

Avg. Two Year Performance

(51%) Avg. Purchase Return
(23%) Compound
4% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return13%4%(19%)(79%)(51%)
Purchase Success Rate2 of 21 of 21 of 21 of 21 of 2
Average Sale Return2%< 1%4%7%4%
Sale Success Rate13 of 2512 of 2512 of 2511 of 258 of 25

Athersys, Inc.

Drugs » Biotechnology

President, COO:

Holdings: 466.53K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--